Yu Xiao

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial.

Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: April 11, 2025

Survival outcomes and prognostic factors of breast cancer spinal metastases: a retrospective study.

Survival outcomes and prognostic factors of breast cancer spinal metastases: a retrospective study.

Journal: Discover oncology
Published: December 04, 2024

Regorafenib with or without chemotherapy/immunotherapy in second-line treatment of metastatic colorectal cancer during the COVID-19 pandemic: a single-center retrospective analysis.

Regorafenib with or without chemotherapy/immunotherapy in second-line treatment of metastatic colorectal cancer during the COVID-19 pandemic: a single-center retrospective analysis.

Journal: Journal of gastrointestinal oncology
Published: November 18, 2024

Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders.

Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders.

Journal: ACS medicinal chemistry letters
Published: June 12, 2024

Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis.

Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis.

Journal: World journal of clinical oncology
Published: March 22, 2024

Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.

Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: March 27, 2022

Tris(1,3-dichloro-2-propyl)phosphate Induces Mass Mortality of Crucian Carp (Carassius carassius) Embryos in Taihu Lake.

Tris(1,3-dichloro-2-propyl)phosphate Induces Mass Mortality of Crucian Carp (Carassius carassius) Embryos in Taihu Lake.

Journal: Environmental science & technology
Published: November 23, 2021

The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer: a multi-center retrospective analysis.

The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer: a multi-center retrospective analysis.

Journal: Anti-cancer drugs
Published: August 09, 2021

Intermittency, Moments, and Friction Coefficient during the Subcritical Transition of Channel Flow.

Intermittency, Moments, and Friction Coefficient during the Subcritical Transition of Channel Flow.

Journal: Entropy (Basel, Switzerland)
Published: October 26, 2020

RNA demethylation increases the yield and biomass of rice and potato plants in field trials.

RNA demethylation increases the yield and biomass of rice and potato plants in field trials.

Journal: Nature biotechnology
Published: September 10, 2019

Antibody-free enzyme-assisted chemical approach for detection of N6-methyladenosine.

Antibody-free enzyme-assisted chemical approach for detection of N6-methyladenosine.

Journal: Nature chemical biology
Published: September 05, 2019

Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.

Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 06, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026